Safety Syringes, headquartered in Carlsbad, Calif., develops anti-needlestick devices for prefilled syringes.
“This pending acquisition is well aligned to BD’s strategy of applying technology and clinical knowledge to make healthcare more effective, efficient and safe,” said William A. Kozy, BD executive vice president, in the release. “Developments for parenteral drug delivery systems continue to be a part of BD’s long-term strategy. This acquisition is intended to provide our BD medical – pharmaceutical systems unit with additional safety features for prefillable syringes, helping to protect against accidental needlesticks by providing safer injections for healthcare workers and end users.”
The acquisition is expected to close by the end of BD’s fiscal year 2012. The financial terms of the agreement were not disclosed.
Becton, Dickinson and Co. is headquartered in Franklin Lakes, N.J.
Related Articles on Company Acquisitions:
Natus Medical Completes Acquisition of CareFusion’s Neurodiagnostic Business
SRI/Surgical Express to be Acquired by Synergy Health
Boston Scientific Completes Acquisition of Cameron Health
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
